Purpose: Radiosurgery is an established technique to treat cerebral arteriovenous malformations (AVMs). Obliteration of larger AVMs (> 10-15 cm 3 or diameter > 3 cm) in a single session is challenging with current radiosurgery platforms due to toxicity. We present a novel technique of multistage stereotactic radiosurgery (SRS) for large intracranial arteriovenous malformations (AVM) using the Gamma Knife system. Materials/Methods: Eighteen patients with large (> 10-15 cm 3 or diameter > 3 cm) AVMs, which were previously treated using a staged SRS technique on the Cyberknife platform, were retrospectively selected for this study. The AVMs were contoured and divided into 3-8 subtargets to be treated sequentially in a staged approach at half to 4 week intervals. The prescription dose ranged from 15 Gy to 20 Gy, depending on the subtarget number, volume, and location. Gamma Knife plans using multiple collimator settings were generated and optimized. The coordinates of each shot from the initial plan covering the total AVM target were extracted based on their relative positions within the frame system. The shots were regrouped based on their location with respect to the subtarget contours to generate subplans for each stage. The delivery time of each shot for a subtarget was decay corrected with 60 Co for staging the treatment course to generate the same dose distribution as that planned for the total AVM target. Conformality indices and dose-volume analysis were performed to evaluate treatment plans. Results: With the shot redistribution technique, the composite dose for the multistaged treatment of multiple subtargets is equivalent to the initial plan for total AVM target. Gamma Knife plans resulted in an average PTV coverage of 96.3 AE 0.9% and a PITV of 1.23 AE 0.1. The resulting Conformality indices, V 12Gy and R 50 dose spillage values were 0.76 AE 0.05, 3.4 AE 1.8, and 3.1 AE 0.5 respectively. Conclusion: The Gamma Knife system can deliver a multistaged conformal dose to treat large AVMs when correcting for translational setup errors of each shot at each staged treatment.
Radiation dose must be decreased with increasing lesion volume to prevent toxicity of surrounding normal tissue, consequently limiting rates of successful obliteration. 7 Several centers have pursued a multistaged, spatially fractionated approach for the treatment of large AVMs using a Gamma Knife treatment platform (Elekta, Stockholm, Sweden). 8, 9 It is hypothesized that increased radiation dose reduces the intracranial hemorrhage risks for large AVMs by improving obliteration rates, and normal tissues adjacent to the total target but away from the staged target subvolume undergo sublethal radiation repair prior to the next stage. Staging AVM treatments by segmenting the total AVM into subvolumes treated as separate targets over a period of several months permits a more potent obliterative dose than could be delivered to the entire volume in a single fraction.
The previously reported Gamma Knife multistage treatment technique has several limitations. With this technique, a separate plan is created for each treatment stage making it difficult to assess the cumulative dose distribution to the total AVM before the final staged treatment. This limits the design of an optimal comprehensive plan. Also, the interval between each staged treatment can be several months, requiring an MRI and Angiogram acquisition for each treatment. The anatomy changes relative to the frame, complicating contouring and the dose prescription, and each angiogram has its independent risk of stroke. With geometric miss, there may be a higher hemorrhage risk of a partially treated AVM. To avoid these limitations, we developed a practical multistage radiosurgery technique using the Cyberknife delivery platform and treatment planning system 10 to assess the cumulative dose of entire staged course before the first staged treatment and reducing stage intervals from 1/2 to 4 weeks. With recent advances to the Gamma Knife platform, such as ICON systems, it may be possible to implement more accurate multistage technique with the Gama Knife system for the treatment of large AVMs.
MATERIALS AND METHODS
This study was approved by the institutional review board and conducted in accordance with institutional guidelines. Eighteen patients diagnosed with large (25.8 AE 17.6 cm 3 ) localized cerebral AVMs shown in Table I , which were previously treated with a multistaged SRS technique on the Cyberknife platform, 10 were selected for this retrospective study. The composite prescription dose ranged from 15 Gy to 20 Gy covering more than 95% of the total AVM volume.
2.A. Target localization
Patients were immobilized and imaged using a 16-slice Brilliance Big Bore CT scanner (Philips Healthcare, Andover, MD, USA) without contrast to be used as the primary image set. A custom-built angiogram localization frame was attached to the head immobilization system and a contrast CT scan and orthogonal Angiogram images were acquired with the patient in the identical position. A T1-weighted MRI image was acquired with gadolinium contrast for improved target definition. A target volume was obtained by contouring the overlapped target outline projection areas from both AP and lateral angiograms. Additional information from the contrast CT and MRI datasets was also used to contour the final AVM nidus. Depending on the target size and shape, each AVM was manually divided into 3-8 sub-targets with approximately equal volumes.
2.B. Technique for splitting the total AVM
The staged planning technique for large AVM is presented as follows. First, the treatment plan is designed with the prescription dose to cover the total AVM target volume. Shots are divided among each subtarget depending on the center of each shot as shown in Fig. 1(a) . If the center of a shot is within a sub-target, then it becomes associated with the corresponding subtarget's staged plan. If the center of a shot is outside the total target area, the shot becomes associated with the subtarget staged plan with the closest minimum distance between the shot center to the weighted center of the subtarget. The cumulated dose distribution of all the staged treatments should be identical to the original plan for the total target.
To simulate this approach, we combine the MRI image of a Gamma Knife frame with the MRI image of each patient (Fig. 2) . The MRI image set with the frame was input into the Leksell Gamma Knife Planning (LGP) system. Treatment planning was performed on the total AVM target area with an identical prescription dose (15-20 Gy) used in the previous Cyberknife staged treatment planning work. 10 The coordinates of each shot are extracted from the planning file of the LGP system and analyzed with in-house software. The shots are resorted and the substage plan is generated by grouping shots within the subtarget region. As each substage plan will be delivered in consecutive stages, the treatment times for each shot are decay adjusted for 60 Co to generate the same dose prescribed on the original planning day. The Perfexion version of Leksell Gamma Knife has the ability to generate composite shots which combine different collimator sizes with eight bands of sources. In this work, composite plans using shots with multiple collimator sizes as well as plans using single collimator sizes with spherical shots are evaluated to verify the robustness of multistage planning technique.
2.C. Treatment planning
Although it is possible to reposition the Gamma Knife frame on the patient's skull with reference markers for each stage, the setup error may reach 5 mm in translations and 3 degrees in rotation with frame repositioning on an anthropomorphic skull phantom in a simulated situation. The 60 Co Sources in each of eight radial sections can only be collimated to 4 mm, 8 mm, 16 mm, or block out.
Combined collimation in a single section is not available. Therefore, the shape of each shot cannot be changed to compensate the rotational error in all three axes. Therefore, we developed a procedure to compensate the translational setup error based on the MRI image registration and the coordinate transform of the center of each shot for each staged treatment based on the optimal 3D coordinate transform 11 as follows.
2.C.1. Shot coordinate conversion from frame to DICOM coordinates A treatment plan as described in Section 2.B is created for the total AVM and split it into multiple stages. The coordinate system for the Gamma Knife frame [X as shown in Fig. 3(a) ] can be defined by the four cross-sectional points ABCD of the linear mark on the frame with the position P(x i ,y i ,z i ) (i = A, B, C or D) in the DICOM coordinate system and P(a i , b i ,c i ) (i = A, B, C or D) in the X coordinate system. The center of each planned shot in the X coordinate system, which is used by the planning system to place the shots, is recorded as S(a,b,c). Then, the centroids of the X and DICOM coordinates are determined to remove the translation between two coordinates. The rotation matrix between the X and DICOM coordinate systems is
Where matrix V and U are from the Singular Value Decomposition (SVD) in Eq. (3) from the covariance matrix, H, which is obtained with Eq. (4).
Therefore, the optimal transformation matrix is:
where t is the translation between coordinates as follows:
For each shot, the optimal converted coordinates in the DICOM system are determined as:
2.C.2. Shot coordinate conversion from DICOM to frame coordinates
The first staged treatment can be delivered when the frame is still attached in its original position to the patient. The frame is re-positioned with the help of skin marks as close as to the original position to achieve optimal position of shots as determined from the initial plan on the total AVM. Errors may occur during the frame repositioning process. Therefore, a new MR image is taken and registered with the original planning MR image in Velocity TM (Varian Medical System, Palo Alto, CA, USA) as shown in Fig. 3(b) .
The coordinate system for the Gamma Knife frame in the new MR image of kth stage is X k , and defined by the four cross-section points A k ,B k ,C k , and D k of the linear marks on the frame with the position of P k (x ki ,y ki ,z ki ) (i = A k , B k , C k , or D k ) in the same DICOM coordinate system from image registration. These four point coordinates
in the X coordinate system. We can use the coordinate transformation Eq. (7) presented in Section 2.C.1 to obtain the transformation matrix between X k and DICOM coordinates as follows:
Where S k (x k ,y k ,z k ) is the center of each planned shot in the DICOM coordinates system, and S k (a k ,b k ,c k ) is the center of each planned shot in the X k coordinate system. M k is the transformation matrix between the kth staged treatment frame matrix, X k , and the DICOM coordinates. Therefore, the shot coordinates in the new frame system are:
Where M k inv is the inverse matrix of M k . As shown in Fig. 3(b) , the center of each shot is the same as the original plan location in DICOM coordinates (e.g., S k ðx k ; y k ; z k ; 1Þ
T ¼ Sðx; y; z; 1Þ T ¼ M Ã Sða; b; c; 1Þ T as of Eq. (7) for corresponding shots, where M is the optimal transformation matrix from the Gamma Knife frame coordinate system, X, to DICOM coordinates at the planning stage and S(a,b,c) is the center position of each shot in frame coordinate, X, for kth stage at the first day when plan was completed. The new shot coordinates in the new Gamma Knife frame system of kth stage are:
These coordinates can be placed manually into the Gamma Knife treatment planning system along with the weight of each shot and corrected shot time. With this method, translational errors between kth stage and planning are corrected, but the rotational error cannot be corrected.
In summary, the planned coordinates of each shot were extracted from Gamma Knife treatment planning system then split according to the subtarget contour using a custom program. After compensation for translational setup errors of each shot as described in the previous section, the coregistered frame coordinates are then manually entered into the Gamma Knife treatment planning system for delivery to the patient.
2.D. Dose volume characteristics
For this study, the dose conformality index recommended by the RTOG for radiosurgery (PITV; ratio of total volume receiving the prescription dose or greater to that of the target volume), the Paddick conformity index (CI), the R 50 (ratio of the volume receiving 50% of the prescription dose or greater to the target volume), and the V 12 Gy (ratio of volume receiving 12 Gy or greater to the volume of the whole brain) indices were used to evaluate the final PTV and normal tissue dose coverage. For planning purposes the PITV was kept as low as achievable and constrained to be less than 2.0.
2.E. Residual rotational error analysis
The rotational error will occur when repositioning the patient with the markers on the frame. Our technique is able to compensate for the translational error during repositioning. To estimate the dose distribution difference induced by residual rotational errors, a systematic analysis was performed for the total AVM target. To simulate this planning technique in the extreme case, a random 5 mm translation combined with rotations of AE1°, AE3°, and AE5°in all three axes of the Gamma Knife frame images were generated before merging with the patient MR image set. The technique in Section 2.C.2 was used to compensate the translation position errors for each shot. Dose distributions were compared between the original planned dose on the total AVM and that resulting from residual rotational errors from the coordinate transform.
2.F. Phantom study for ICON system
The Leksell Gamma Knife â Icon TM is a novel image guided radiosurgery system which integrates the Gamma Knife Perfexion delivery system with Cone Beam CT (CBCT), providing increased workflow flexibility with planning on frameless images and subsequent frameless dose delivery. With the help of the ICON system, the patient can be repositioned to the original planned position with minimal intrafraction position errors, making it attractive for staged AVM treatments.
As shown in Figs. 4(a) and 4(b), an anthropomorphic phantom with accurately aligned EBT3 Gafchromic TM film (Ashland, Lexington, KY, USA) is used to evaluate the accuracy in the ability to deliver a multistage plan to large AVM targets. The simulated target is approximately 3 cm in diameter and split into three stages. The plan for entire AVM target was delivered as a reference without any setup errors as shown in Fig. 4(c) . Staged plans were then delivered to the phantom with random setup errors to simulate real treatment conditions [ Fig. 4 
(d)-4(f)]. A flat panel scanner, Epson
Expression 10000XL (Seiko Epson Corp., Nagano, Japan), was used to scan the film. RIT V6.4 (Radiological Imaging Technology, Inc, Colorado Springs, CO, USA) was used to compare dose differences between staged deliveries to the reference.
RESULT AND DISCUSSION
As discussed in the methods section, the entire treatment workflow was successfully commissioned for the treatment of large AVMs using the Gamma Knife delivery platform and treatment planning systems. Based on quality assurance testing, stereotactic localization of the each shot center within the AVM target in the multistage treatment is achievable within 1 mm.
This novel treatment delivery technique is beneficial in that the radiation oncologist and physicist can design the final dose distribution for the entire AVM on the first day before any dose delivery. Then this 'total' dose distribution is simply broken up into subsequent staged plans so that the cumulative dose matches that of the 'total' dose distribution. Physicians have the freedom to split the total AVM target in any subtarget combinations. This is advantageous for designing a conformal dose distribution to the target volume and avoiding excess dose to adjacent normal structures, such as the optic nerves and brain stem. Table II shows the parameters used for planning and evaluation for the eighteen patients of this study. Dose distributions were optimized to achieve approximately 95% PTV coverage with a PITV conformity index as low as achievable. All 18 patients achieved planning objectives in all planning methods (96.0 AE 0.6%, 96.1 AE 0.8% and 96.3 AE 0.9% for Cyberknife inverse planning, Gamma Knife with multicollimator composite shots and with spherical shots respectively). The average CI value, a measure of the compactness of the high dose distribution to an intended target and the location of the prescription isodose volume relative to the target volume, was similar for the inverse planning technique to that common for smaller AVMs using the Gamma Knife Perfexion or Cyberknife systems (0.80). 12 A value close to 1.0 is expected to minimize radiation related complications. In this work, the CI is close to that of single small targets (CI at 0.78 AE 0.08, 0.78 AE 0.06, and 0.76 AE 0.05 for Cyberknife inverse planning and Gamma Knife with multicollimator composite shots and spherical shots, respectively) indicating that the novel planning technique that is feasible to deliver conformal dose to large target volumes.
Dose-volume effects and parameters which correlate well with normal tissue complications for the staged treatment of large-volume AVMs have yet to be determined. PITV and R 50 represent the ratio of the 100% and 50% of prescription dose volume, respectively, relative to the target volume. As shown in Table I . All planning techniques have similar dose spread surrounding the target volume. The V 12Gy index has been observed to correlate with the risk of developing SRS-related imaging changes and has been used as a surrogate for normal tissue damage. The volume receiving 12 Gy is minimized in staged treatments, regardless of the number of stages used. 13 In this work, the composite V 12 Gy was less than 10% of the brain volume for all patients. This parameter continues to be used for plan evaluation and comparison as experience is gained in staged treatments of large AVMs. Figure 5 shows the statistics of dose distribution difference inside the total AVM target volume for the staged treatment due to simulated residue rotational error. It is clear that the dose difference increases with increasing degree of residue rotation error. In Table III , the volume of the target having a dose difference within 3% is decreased with larger residual rotational errors (98.28%, 84.22% and 68.08% for AE1°, AE3°, and AE5°rotation, respectively, for a composite shot plan). The volume of the target with a dose difference within 5% (99.89%, 94.86% and 83.01% for AE1°, AE3°, and AE5°rotation, respectively, for a composite shot plan) indicates that rotation less than AE3°is acceptable for treatment which can be achieved with marks placed on both the patient skin and frame. A composite shot plan with variable collimator settings and a shaped dose distribution was expected to have larger dose differences with rotational errors when compared with a single collimator spherical shot plan, but interestingly, our results show that the influence is insignificant (93.8% (spherical shots) vs. 94.86% (composite shots) for AE3°rotation). The influence of shot position, target location, and skull shape on rotational errors and effects on dose differences are commendable topics for future study. The ratio of prescription dose coverage, PITV, CI, V 12 Gy , and R 50 between staged delivery dose to planning dose was shown in Table III as well. There is no statistical difference in all these parameters for the staged dose delivery with the remaining rotation error after correction of translational error. The effect of rotational error on the dose distribution increases with the increase in distance to the shot center. Therefore, the high dose region which is critical to target control was less prone to impacted by random rotation error. However, systematical rotation of staged treatment should be avoided.
The ICON system can compensate for translational setup errors of each shot, but cannot compensate for rotational errors. With the frameless mask system, the maximum setup error observed with our phantom was less than 1 degree about any rotational axis and 1 mm in any translational direction. However, to simulate large rotation and translation errors up to 5 degrees and 5 mm, respectively, fixation bolts of the mask were released. A gamma passing criteria of 3% and 1 mm was used with the entire plan delivered in one session to film as the reference and a multistaged delivery with up to 5 mm in translational errors and 5 degrees in rotational errors in all directions. A gamma passing rate of 95.9 AE 3.2% was observed.
Our group has a history with staged treatment of large AVMs using the Cyberknife system. 10 It is interesting to compare the Cyberknife and Gamma Knife techniques. The influence of residual setup error for each stage with the Cyberknife platform is minimized by robotic positioning compensation based on X-ray imaging. However, with our Cyberknife technique, it is cumbersome to split the monitor units for each beam for each subtarget plan and manually change it in the treatment planning system. Furthermore, once subtargets are split and each staged plan is created, it can be very difficult to change the plan if the physician wishes to change the subtarget to avoid a high dose for certain critical organs in a single stage. Although there is no method to compensate for residue rotational errors with the Gamma Knife platform, it is clear from this work that the influence of this error is insignificant for the cumulative dose to the total AVM target. Additionally, the shot splitting technique for the Gamma Knife is less cumbersome when compared to monitor unit splitting with the Cyberknife platform. Furthermore, staged plans with the Gamma Knife technique are more easily adaptable if any changes to subtargets are requested by the physician to avoid single stage high dose to critical organs. Shots can be simply switched between subtargets.
CONCLUSION
The Gamma Knife system can deliver a multistaged conformal dose to treat large AVMs with the ICON systems. The Gamma Knife system can also deliver staged AVM treatments for large AVMs without these additional systems when correcting for translational setup errors. Rotational setup erros, which cannot be corrected for, have little effect on the dose distribution to the AVM target for the Gamma Knife technique. Target coverage and prescription dose conformality were shown to be similar to that of a single target, single fraction treatment.
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